Biological Response of Stage IV Knee Osteoarthritis to Serial 12.5% Dextrose
Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
Dextrose injection in end-stage knee arthritis will cause growth of cartilage cells in a
particular area of complete cartilage loss. Dextrose concentration will be 12.5%. Cartilage
status will be monitored by pre and post treatment arthroscopy views with specialized
(methylene blue) staining for cartilage.